Delivery Order SPE2DX22D0079-SPE2D826FAAB5
- Not listed
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a $18,070.38 firm fixed-price delivery order to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3), the pharmaceutical distributor's Corporate Office division, on August 25, 2025, with an ultimate completion date of August 26, 2025. This competitively awarded, non-set-aside contract represents a child order under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) vehicle with DLA Troop Support Medical (SPE2DX), valued at...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $15,484.50 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on October 7, 2025, with an ultimate completion date of October 8, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $791,968.14 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on October 1, 2025, with an ultimate completion date of October 2, 2025. This firm fixed-price, non-set-aside delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. AmerisourceBergen,...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $11,367.90 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on July 18, 2025, with an ultimate completion date of July 21, 2025. This firm fixed-price, non-set-aside contract represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The performance location is...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a $1,860.48 delivery order to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on May 30, 2025, with an ultimate completion date of June 2, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The place of performance is located...
- The U.S. Defense Logistics Agency's Medical Supply Chain has awarded a delivery order valued at $70,561.85 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3), a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. This competitive award, issued on September 29, 2025, with a completion date of September 30, 2025, is structured as a firm fixed-price delivery order with no set-aside designation. The order represents a child contract under AmerisourceBergen's larger...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a $12,185.65 firm fixed-price delivery order to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on September 1, 2025, with an ultimate completion date of September 2, 2025. The delivery order was issued without set-aside designation through open competition and is classified as a child contract under a larger vehicle. AmerisourceBergen's Corporate Office, based in Conshohocken, Pennsylvania, serves as the place of performance...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order contract valued at $7,931.00 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on September 22, 2025, with a completion date of September 23, 2025. This firm fixed-price delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999.9M and extending through December 2026. The contract carries no set-aside designation and was...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $17,967.81 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on July 5, 2025, with an ultimate completion date of July 7, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and critical federal healthcare vendor,...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $50,749.47 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on September 8, 2025, with completion scheduled for September 9, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through...
- SPE2DX22D0079Indefinite Delivery Contract
- SPE2DX22D0079-SPE2D826FAAB5Delivery Order
The U.S. Defense Logistics Agency's Medical Supply Chain awarded a $74,103.20 delivery order to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on October 6, 2025, with an ultimate completion date of October 7, 2025. This firm fixed-price delivery order, which is a child contract under AmerisourceBergen's larger vehicle, was competitively awarded without a set-aside designation. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen fulfills critical medical procurement needs for military and veteran healthcare systems, supplying an extensive portfolio of pharmaceutical products including brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities. This delivery order supports the Defense Logistics Agency's pharmaceutical supply operations through AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and active through December 2026. This prime indefinite delivery vehicle enables AmerisourceBergen to provide comprehensive global pharmaceutical support across multiple therapeutic domains to customers including the Defense Health Agency and U.S. Coast Guard. The company's demonstrated capability to meet federal procurement requirements through open competition, combined with its versatility in fulfilling orders ranging from small transactions to substantial orders exceeding $45,000, positions it as a key vendor supporting military healthcare programs worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $74.1k | 10/6/25 |